Mustafa is a 60-year-old former smoker with severe COPD and cardiac disease associated with frequent episodes of bronchospasm. Which of the following is a bronchodilator useful in chronic obstructive pulmonary disease (COPD) and least likely to cause cardiac arrhythmia?
Rationale:
D: Ipratropium is a bronchodilator that works by relaxing the airways, making it particularly suitable for COPD patients. It has minimal cardiovascular effects, making it least likely to induce arrhythmias in patients with cardiac disease.
A: Aminophylline can stimulate the heart, increasing the risk of arrhythmias, which is concerning for patients with existing cardiac conditions.
B: Cromolyn is primarily a mast cell stabilizer and does not function as a bronchodilator, making it ineffective for treating COPD symptoms directly.
C: Epinephrine is a potent bronchodilator but can significantly elevate heart rate and provoke arrhythmias, posing risks for individuals with cardiac disease.
A drug useful in the treatment of asthma but lacking bronchodilator action, is
Rationale:
A drug useful in the treatment of asthma but lacking bronchodilator action is Cromolyn.
Cromolyn stabilizes mast cells and prevents the release of inflammatory mediators, thus reducing airway inflammation and bronchoconstriction. This mechanism makes it effective for asthma management without exhibiting direct bronchodilation effects, differentiating it from other treatment options.
B: Ephedrine This option acts as a bronchodilator, stimulating beta-adrenergic receptors to relax bronchial smooth muscle and alleviate asthma symptoms, which contradicts the requirement of lacking bronchodilator action.
C: Isoproterenol This substance is also a potent bronchodilator, functioning through beta-adrenergic stimulation to enhance airway dilation, thus failing to meet the criteria of not having bronchodilator action.
D: Metaproterenol Similar to isoproterenol, this medication is designed to relax bronchial muscles and is classified as a bronchodilator; hence, it does not fit the specified condition of lacking bronchodilator effects.
If therapy with multiple drugs causes induction of drug metabolism in your asthma patient, it will
Rationale:
Result in increased smooth endoplasmic reticulum. Induction of drug metabolism through polypharmacy leads to an upregulation of enzymes involved in detoxification processes, primarily localized in the smooth endoplasmic reticulum of liver cells, enhancing metabolic capacity.
B: Result in increased rough endoplasmic reticulum. The rough endoplasmic reticulum is primarily associated with protein synthesis, not drug metabolism, which relies more on the smooth endoplasmic reticulum.
C: Result in decreased enzymes in the soluble cytoplasmic fraction. Drug metabolism induction generally enhances enzyme production rather than decreases it, contradicting the expected physiological response to increased drug exposure.
D: Require 3-4 months to reach completion. While some metabolic adaptations may take time, the induction process can begin within days to weeks, making this timeframe inaccurate for immediate metabolic changes.
The most consistent, pronounced and sustained relief of symptoms in chronic bronchial asthma is afforded by
Rationale:
Corticosteroids provide the most consistent, pronounced, and sustained relief of symptoms in chronic bronchial asthma. They effectively reduce inflammation and prevent exacerbations, leading to improved lung function and symptom control over time.
A: β₠sympathomimetics Primarily offer short-term bronchodilation and do not adequately address the underlying inflammation associated with chronic asthma, making them less effective for long-term symptom relief.
B: Anticholinergics Mainly provide temporary relief by inhibiting bronchoconstriction but lack the long-lasting anti-inflammatory effects necessary for managing chronic asthma symptoms sustainably and effectively.
C: Sodium cromoglycate Primarily acts as a mast cell stabilizer, preventing the release of inflammatory mediators, yet its efficacy is limited compared to corticosteroids in providing sustained symptom control in chronic asthma.
What is symport?
Rationale:
Symport is cotransport. This process involves the simultaneous transport of two substances across a cell membrane in the same direction, utilizing a specific transporter protein to facilitate their movement together.
A: Counter transport involves the movement of two substances in opposite directions, contrasting with symport's simultaneous transport in one direction.
C: Carrier mediated diffusion refers to facilitated transport of a single molecule, which does not encompass the dual movement characteristic of symport.
D: Solvent drug pertains to the context of pharmaceuticals and their interactions, not the transport mechanisms described in cellular biology.
A 51-year-old male patient with asthma has been prescribed an albuterol breathing treatment via small volume nebulizer. Before initiating the therapy, you note from the chart that the patient is severely hypertensive and has been experiencing episodes of supraventricular tachycardia. Which of the following actions should you take at this time?
Rationale:
C: Postpone the treatment and consult the physician. Given the patient's severe hypertension and episodes of supraventricular tachycardia, it's critical to prioritize safety by delaying the treatment and seeking further medical guidance to avoid exacerbating his condition.
A: Provide acetylcysteine instead of albuterol. This action does not address the acute asthma treatment needed and fails to consider the patient's cardiovascular status, which complicates the situation further.
B: Dilute the albuterol with extra normal saline. While dilution may seem helpful, it does not mitigate the underlying risks associated with the patient's hypertensive state and tachycardia during treatment.
D: Administer the treatment as ordered. Proceeding with the albuterol treatment without addressing the patient's significant cardiovascular issues could lead to severe complications, making this option highly inappropriate.
Relatively higher dose of theophylline is required to attain therapeutic plasma concentration in
Rationale:
Relatively higher dose of theophylline is required to attain therapeutic plasma concentration in smokers. Smokers metabolize theophylline more rapidly due to increased enzyme activity from cigarette smoke, necessitating larger doses to achieve effective treatment levels.
B: Congestive heart failure patients typically have altered pharmacokinetics, often requiring lower doses of theophylline to prevent toxicity rather than higher doses for therapeutic effects.
C: Those receiving erythromycin experience increased theophylline levels due to erythromycin's inhibition of its metabolism, leading to a need for lower doses to avoid adverse effects rather than higher doses.
D: Those receiving cimetidine face reduced theophylline clearance due to cimetidine's inhibitory effect on liver enzymes, which would require careful monitoring and potentially lower theophylline doses rather than increasing them.
Concerning the inhaled asthma reliever salbutamol, which of the following is INCORRECT:
Rationale:
Salbutamol may produce bradycardia. This statement is incorrect as salbutamol primarily stimulates beta-2 adrenoceptors, leading to bronchodilation and typically does not induce bradycardia, which is generally associated with beta-1 stimulation.
A: It stimulate beta-2 adrenoceptors. Salbutamol is designed to activate beta-2 adrenoceptors specifically, resulting in effective relaxation of bronchial smooth muscle and improved airflow during asthma attacks.
C: It relax bronchial smooth muscle. The primary action of salbutamol involves relaxing bronchial smooth muscle, enhancing airway patency and facilitating easier breathing for individuals experiencing asthma symptoms.
D: It is used by inhalation or oral. While salbutamol can be delivered via inhalation, oral administration is less common and not the preferred route for rapid asthma relief, thus misleading.
You are called to administer a nebulized albuterol treatment to a 47-year-old female patient that is receiving oxygen via binasal cannula at 2 L/min. Her pretreatment heart rate was recorded at 84 beats/min. You would stop the treatment if the patient's heart rate were to reach which of the following:
Rationale:
If the patient's heart rate were to reach 119 beats/min, the treatment would need to be stopped.
Albuterol can lead to increased heart rate, and a significant rise beyond normal limits, such as 119 beats/min, indicates potential cardiovascular stress. Monitoring heart rate is crucial during nebulization, as elevated rates may necessitate treatment cessation to ensure patient safety and prevent adverse effects.
A: 89 beats/min This heart rate is within the normal range and does not indicate a need to stop treatment, as it reflects minimal change from the baseline.
B: 99 beats/min While this heart rate shows an increase, it remains below a critical threshold and does not pose an immediate risk to the patient's safety during treatment.
C: 109 beats/min Although this shows a considerable rise, it still falls short of the level where intervention would be necessary to safeguard the patient's health during the nebulization.
Budesonide is a
Rationale:
Budesonide is an inhaled corticosteroid for asthma. This classification is accurate as budesonide effectively reduces inflammation in the airways, making it a vital treatment option for asthma management by improving respiratory function.
A: Nonsteroidal anti-inflammatory drug. This option misidentifies budesonide, as it functions specifically as a corticosteroid, not as a nonsteroidal anti-inflammatory agent, which operates through different mechanisms.
B: High ceiling diuretic. Budesonide does not fall under the diuretic category; it serves a different purpose related to asthma treatment and inflammatory response, unrelated to fluid regulation.
D: Contraceptive. Budesonide has no relation to contraceptive methods, as it is primarily utilized for managing asthma and does not influence reproductive health or prevent pregnancy.
A 22-year-old female patient has just arrived to the emergency department with acute bronchospasm. Which of the following medications would you recommend?
Rationale:
Albuterol (Proventil) is the recommended medication for acute bronchospasm. This beta-agonist works by relaxing bronchial smooth muscles, providing rapid relief of airflow obstruction and alleviating symptoms associated with bronchospasm.
B: Racemic epinephrine primarily treats upper airway edema and is not the first choice for bronchospasm, as it lacks the targeted bronchodilatory effects needed in this acute situation.
C: Cromolyn sodium (Intal) serves as a prophylactic agent for asthma but does not provide immediate relief for acute bronchospasm, making it unsuitable in emergency scenarios.
D: Acetylcysteine (Mucomyst) acts as a mucolytic agent, which aids in breaking down mucus but does not address the immediate need for bronchodilation in acute bronchospasm cases.
The following drugs are used as 'standard of care' when treating a patient with type II (hypoxic-hypercapnic) respiratory failure:
Rationale:
A: 35 per cent oxygen. This option is essential for managing type II respiratory failure as it helps to improve oxygenation and alleviate hypoxia, thereby enhancing the patient’s overall respiratory function.
B: Doxapram. While it stimulates respiratory drive, it does not address the hypoxia or hypercapnia directly and is not considered standard care for this specific condition.
C: Salbutamol. Although it is a bronchodilator that can relieve airway constriction, it does not provide sufficient oxygenation or directly treat hypoxic-hypercapnic respiratory failure effectively.
D: Methylprednisolone. This corticosteroid can reduce inflammation, but it does not directly improve oxygenation or address the underlying respiratory failure in a standard treatment regimen.
A male patient was just prescribed an inhaled corticosteroid via MDI for two puffs twice a day. In order to decrease the likelihood of an oral infection, which of the following would you recommend that the patient do?
Rationale:
D: Rinse his mouth and gargle with water after inhalation. This practice helps to clear residual medication from the oral cavity, significantly reducing the risk of developing oral infections associated with inhaled corticosteroids.
A: Receive concurrent bronchodilator therapy. While bronchodilators can aid in respiratory function, they do not address the specific risk of oral infections linked to corticosteroid use.
B: Be prescribed an appropriate antibiotic. Antibiotics target bacterial infections, but they do not prevent the oral infections that may arise from inhaled corticosteroid use.
C: Decrease the frequency to once per day. Reducing the dosage may not effectively mitigate the risk of oral infections and could compromise the therapeutic benefits of the medication.
Montelukast:
Rationale:
Montelukast is a competitive antagonist at the Cys LT1 receptor. This action prevents leukotrienes from binding, thereby reducing inflammation and bronchoconstriction, making it effective in managing asthma and allergic rhinitis.
B: Can be given orally. While montelukast is indeed available in oral form, this fact does not speak to its unique mechanism of action as a receptor antagonist.
C: Is usually taken once daily at bedtime. The timing of administration, though important for efficacy, does not define the drug's pharmacological role as a competitive antagonist at the receptor site.
D: May be associated with Churg-Strauss syndrome. Although there is a potential link to this syndrome, it does not pertain to the drug's primary function as a competitive antagonist at the Cys LT1 receptor.
The action of 5-Hydroxy tryptamine mediated by the 5-HT₃ receptor is
Rationale:
Bradycardia. The mediation of 5-Hydroxy tryptamine through the 5-HT₃ receptor prominently influences heart rate, leading to a decrease in cardiac output, hence resulting in bradycardia, which is a slower heart rate.
A: Vasoconstriction. This action typically involves other receptors, such as alpha-adrenergic ones, rather than the 5-HT₃ receptor, which primarily relates to cardiac functions and not vascular tone.
C: EDRF release. Endothelium-derived relaxing factor (EDRF) is associated with different receptor pathways, not directly linked to the 5-HT₃ receptor, which is focused on cardiac response rather than vascular relaxation.
D: Platelet aggregation. While serotonin influences platelet function, the 5-HT₃ receptor specifically does not mediate this process, as other receptors are more crucial for regulating platelet aggregation.
A 55-year-old patient that is receiving aerosol therapy with 0.9% saline is unable to produce an acceptable volume of sputum for a sample. Which of the following would you recommend at this time?
Rationale:
Change to hypertonic saline. Hypertonic saline can help in producing an acceptable volume of sputum by promoting better hydration of the airway secretions, thus facilitating effective expectoration during aerosol therapy.
A: Initiate chest physiotherapy. While chest physiotherapy can aid in clearing secretions, it may not directly enhance sputum production as quickly as changing the saline concentration would.
B: Administer the aerosol continuously. Continuous aerosol administration may not significantly improve sputum volume if the saline concentration is insufficient to adequately hydrate secretions for expectoration.
D: Perform nasotracheal suctioning. Nasotracheal suctioning is an invasive procedure that may not be necessary at this moment, especially when modifying aerosol therapy could yield better sputum production results.
Fall in blood pressure caused by larger doses of histamine is blocked by
Rationale:
Combination of H₠‚ and H₠antagonists. This combination effectively mitigates the drop in blood pressure induced by larger histamine doses, highlighting the complementary roles of both antagonists in counteracting histamine's vascular effects.
A: Hâ‚ antihistaminics alone. This option fails to address the specific receptors involved in blood pressure regulation, limiting its effectiveness against the broader impact of histamine.
B: Hâ‚‚ antagonists alone. Targeting only Hâ‚‚ receptors does not provide adequate protection against blood pressure changes caused by histamine, as it overlooks Hâ‚ receptor involvement.
D: None of the above. This choice disregards the established pharmacological strategies available for managing histamine-induced hypotension, overlooking the potential benefits of using a combination of antagonists.
In the emergency department, the preferred first-line therapy for asthma exacerbation is
Rationale:
B: A β-agonist. This treatment rapidly relaxes bronchial smooth muscle, providing immediate relief from bronchospasm during an asthma exacerbation, making it the most effective first-line option in emergency situations.
A: Theophylline. While it can help with asthma symptoms, its slower onset and potential side effects make it less suitable as an initial emergency treatment compared to a beta-agonist.
C: A corticosteroid. Although corticosteroids are crucial for long-term management and reducing inflammation, they take time to exert their effects and are not ideal for immediate relief in acute situations.
D: Cromolyn sodium. This medication serves as a preventive measure rather than a rescue treatment, making it inappropriate for addressing the urgent symptoms of an asthma exacerbation in the emergency department.
Histamine
Rationale:
Histamine may be released from mast cells by a number of therapeutic agents. This statement is accurate as various medications, such as certain antihistamines and immunomodulators, can trigger mast cells to release histamine, influencing allergic and inflammatory responses in the body.
B: Causes sedation Histamine primarily promotes wakefulness and alertness, contradicting the notion that it induces sedation, which is more characteristic of other neurotransmitters like gamma-aminobutyric acid (GABA).
C: Decreases the force of contraction of ventricular muscle Histamine generally enhances cardiac contractility through H2 receptors, making this option misleading as it does not accurately reflect histamine's effects on cardiac function.
D: Can cause strong contractions of the gravid human uterus While histamine can influence various smooth muscles, it does not specifically induce strong contractions in the pregnant uterus, which is more affected by hormones like oxytocin.
Which of the following is most useful in the treatment of hyperprolactinemia?
Rationale:
Bromocriptine effectively reduces prolactin levels by acting as a dopamine agonist, stimulating dopamine receptors and inhibiting prolactin secretion from the pituitary gland, thus treating hyperprolactinemia efficiently.
B: Cimetidine primarily functions as an H2 receptor antagonist for gastrointestinal issues and does not have a direct impact on prolactin levels or treat hyperprolactinemia effectively.
C: Ergotamine is primarily used for migraine treatment and does not address the underlying causes of hyperprolactinemia, making it unsuitable for this condition.
D: Ketanserin acts as a serotonin receptor antagonist, primarily influencing blood pressure, and lacks efficacy in managing prolactin levels in hyperprolactinemia cases.
A patient suffering from 'status asthmaticus' presents in the emergency room. Which of the following in its parenteral form is life saving for this patient, and acts by inhibition of phospholipase $A_2$?
Rationale:
Dexamethasone/prednisolone is a life-saving intervention for status asthmaticus, acting by inhibiting phospholipase A₂, which reduces inflammation and bronchoconstriction, allowing for improved airflow and respiratory function.
A: Aminophylline does not primarily target phospholipase A₂; instead, it acts as a bronchodilator by inhibiting phosphodiesterase, which does not directly address the severe inflammation in status asthmaticus.
B: Cromolyn is a mast cell stabilizer that prevents the release of inflammatory mediators but does not act through phospholipase A₂ inhibition, making it less effective in acute severe asthma situations.
C: Epinephrine primarily acts as a bronchodilator and stimulates adrenergic receptors, but it does not inhibit phospholipase A₂, thus lacking the specific anti-inflammatory action needed for status asthmaticus.
Acute exacerbations of asthma can be triggered by all of the following except
Rationale:
Acute exacerbations of asthma can be triggered by all of the following except hot, dry weather.
Hot, dry weather does not typically provoke asthma attacks; rather, it can sometimes be tolerable for individuals with asthma. Other options, like infections or medication changes, are more directly linked to exacerbations of asthma symptoms.
A: Bacterial or viral pneumonia Infections like pneumonia can lead to significant respiratory distress, often exacerbating asthma symptoms and increasing the likelihood of acute attacks.
B: Hypersensitivity reaction to penicillin Allergic reactions to medications such as penicillin can trigger asthma exacerbations by causing airway inflammation and increased bronchial sensitivity.
C: Discontinuation of asthma medication Stopping asthma medication can result in inadequate control of airway inflammation, leading to a higher risk of exacerbations and worsening asthma management.
In a patient of bronchial asthma, inhaled salbutamol produces the following effect(s).
Rationale:
Causes bronchodilatation.
Salbutamol is a beta-2 adrenergic agonist that relaxes bronchial smooth muscle, leading to dilation of the airways. This effect alleviates symptoms of bronchial asthma, enhancing airflow and improving respiratory function in affected patients.
A: Inhibits antigen-antibody reaction in the lungs. Salbutamol does not directly influence immune responses or inhibit the formation of antigen-antibody complexes within the pulmonary system.
C: Reduces bronchial hyperreactivity. While salbutamol can improve airflow, it does not specifically target or reduce the underlying bronchial hyperreactivity associated with asthma, which involves more complex immune processes.
D: Both (b) and (c). Although salbutamol effectively causes bronchodilatation, it does not reduce bronchial hyperreactivity, meaning this option inaccurately combines effects that are not both achieved by salbutamol.
Which of the following is a prophylactic agent that appears to stabilize mast cells?
Rationale:
B: Cromolyn stabilizes mast cells by inhibiting their degranulation, which prevents the release of inflammatory mediators such as histamine. This action helps manage allergic reactions and asthma symptoms effectively.
A: Aminophylline is a bronchodilator that relaxes airway muscles but does not have a direct role in mast cell stabilization. Its primary function is to improve airflow in respiratory conditions.
C: Epinephrine acts as a vasoconstrictor and bronchodilator, providing rapid relief during anaphylaxis. However, it does not stabilize mast cells, focusing instead on immediate symptom relief.
D: Ipratropium is an anticholinergic agent that helps reduce bronchospasm by blocking muscarinic receptors. Its mechanism does not involve mast cell stabilization, making it unsuitable for this purpose.
The smooth muscle stimulating action of 5-HT is most marked in the
Rationale:
The smooth muscle stimulating action of 5-HT is most marked in the intestines. This is due to 5-HT's significant role in regulating gastrointestinal motility, enhancing peristalsis, and promoting digestive processes, thereby demonstrating its pronounced effect on intestinal smooth muscle contraction compared to other smooth muscle types in the body.
A: Bronchi 5-HT's stimulation of smooth muscle in the bronchi is less prominent, as bronchial smooth muscle contraction is primarily influenced by other mediators like acetylcholine and histamine.
C: Ureter While 5-HT may influence ureteral contractions, its impact is overshadowed by other factors, such as hormonal regulation and interstitial cells of Cajal, which primarily control ureteral motility.
D: Biliary tract Although 5-HT can affect biliary smooth muscle, its overall effect is minimal compared to the dominant regulatory mechanisms involving hormones and neural control specific to bile flow.
The antihistamine which has calcium channel blocking and labyrinthine suppressant property is
Rationale:
B: Cinnarizine possesses both calcium channel blocking and labyrinthine suppressant properties, making it effective in treating motion sickness and vestibular disorders, in addition to its antihistaminic effects, enhancing its therapeutic profile.
A: Cyproheptadine primarily acts as an antihistamine with some serotonin antagonist properties, lacking the calcium channel blocking or labyrinthine suppression characteristics present in Cinnarizine.
C: Clemastine is mainly an antihistamine without significant calcium channel blocking or labyrinthine suppressant effects, which limits its application in conditions requiring those specific properties.
D: Cetirizine is a second-generation antihistamine known for its minimal sedation effects and does not exhibit calcium channel blocking or labyrinthine suppression, making it unsuitable for those conditions.
A 16-year-old patient is in the emergency room receiving nasal oxygen. She has a heart rate of $135 /min$, a respiratory rate of $40/min$. Wheezing and rales are audible without a stethoscope. Which of the following drugs does NOT have a direct bronchodilator effect?
Rationale:
C: Nedocromil is the correct answer as it functions primarily as a mast cell stabilizer and does not act directly on bronchial smooth muscle to induce bronchodilation, unlike the other options.
A: Epinephrine activates β-adrenergic receptors, leading to smooth muscle relaxation and bronchodilation, making it a potent bronchodilator in respiratory distress situations, particularly in emergencies.
B: Terbutaline is a selective β2-adrenergic agonist that specifically targets airway smooth muscle, resulting in effective bronchodilation and improved airflow during asthma or other obstructive airway conditions.
D: Theophylline enhances bronchial dilation through phosphodiesterase inhibition, leading to increased cAMP levels in smooth muscle cells, thereby promoting bronchodilation and improved respiratory function in patients with airway constriction.
The following drugs can be used in treatment of bronchial asthma EXCEPT:
Rationale:
D: Carbachol is not used in the treatment of bronchial asthma as it is a cholinergic agent that can induce bronchoconstriction. Asthma management requires bronchodilators or anti-inflammatory medications to alleviate symptoms and improve airflow, making Carbachol unsuitable.
A: Aminophylline acts as a bronchodilator but is less commonly utilized today in asthma management due to side effects and the availability of more effective treatments.
B: Salbutamol is a selective beta-2 agonist and a primary rescue medication for asthma, providing rapid relief from bronchospasm and improving breathing during acute asthma attacks.
C: Ketotifen is an antihistamine with additional anti-inflammatory properties, used as a maintenance treatment in asthma, but it does not directly relieve acute bronchospasm like other options.
Terbutaline specifically stimulates:
Rationale:
Terbutaline specifically stimulates Beta 2 receptors. This medication acts on beta-2 adrenergic receptors predominantly found in the bronchial tissues, leading to bronchodilation and relief from asthma or COPD symptoms, making it effective for respiratory conditions.
A: Alpha 1 receptors Targeting alpha-1 receptors primarily leads to vasoconstriction, which is unrelated to terbutaline's function in promoting airway dilation and relaxation, contradicting its therapeutic purpose.
B: Alpha 2 receptors Stimulation of alpha-2 receptors typically results in inhibition of neurotransmitter release, impacting blood pressure and sedation, rather than facilitating the bronchodilation that terbutaline is designed to achieve.
C: Beta 1 receptors Activation of beta-1 receptors predominantly affects cardiac function, increasing heart rate and contractility, which does not align with terbutaline's role in treating respiratory issues by targeting airway smooth muscle.
In the emergency department, the preferred first-line therapy for asthma exacerbation is
Rationale:
A β-agonist is the preferred first-line therapy for asthma exacerbation.
This choice is supported by its rapid action in bronchodilation, effectively relaxing airway smooth muscles and improving airflow. A β-agonist quickly alleviates symptoms during acute asthma attacks, making it essential for emergency treatment in the emergency department setting.
A: Theophylline has a delayed onset of action, making it unsuitable for immediate relief during acute asthma exacerbations.
C: A corticosteroid is valuable for long-term management and inflammation reduction but does not provide the rapid bronchodilation required in acute situations.
D: Cromolyn sodium functions as a preventive treatment and lacks the immediate effect necessary to address acute asthma exacerbations effectively.
Mustafa is a 60-year-old former smoker with severe COPD and cardiac disease associated with frequent episodes of bronchospasm. Which of the following is a bronchodilator useful in chronic obstructive pulmonary disease (COPD) and least likely to cause cardiac arrhythmia?
Rationale:
D: Ipratropium is a bronchodilator that is less likely to stimulate the heart's adrenergic receptors, making it a safer option for patients with cardiac issues, such as Mustafa’s cardiac disease. Its anticholinergic properties provide effective relief from bronchospasm without significant cardiovascular side effects, making it ideal for managing severe COPD in patients with additional cardiac concerns.
A: Aminophylline has stimulant effects that can elevate heart rate and potentially induce arrhythmias, posing risks for patients like Mustafa with existing cardiac disease and complicating their COPD management.
B: Cromolyn primarily serves as a mast cell stabilizer rather than a bronchodilator. It does not directly alleviate bronchospasm in COPD, limiting its effectiveness for Mustafa's respiratory issues.
C: Epinephrine is a potent bronchodilator but can significantly increase heart rate and provoke arrhythmias, making it unsuitable for patients with cardiac conditions like Mustafa’s severe COPD and cardiac disease.
A drug useful in the treatment of asthma but lacking bronchodilator action, is
Rationale:
Cromolyn is a drug useful in the treatment of asthma but lacking bronchodilator action. Cromolyn stabilizes mast cells and prevents the release of inflammatory mediators, making it effective in managing asthma without directly dilating the airways. Its unique mechanism distinguishes it from other asthma medications that primarily function as bronchodilators.
B: Ephedrine stimulates adrenergic receptors, leading to bronchodilation and increased airflow, contradicting the requirement for a drug that lacks such bronchodilator action.
C: Isoproterenol acts as a potent bronchodilator by stimulating beta-adrenergic receptors, fulfilling the opposite of the requirement for a drug without bronchodilator effects.
D: Metaproterenol is a selective beta-2 agonist that provides significant bronchodilation, thus not suitable for the definition of a drug lacking bronchodilator action.
If therapy with multiple drugs causes induction of drug metabolism in your asthma patient, it will
Rationale:
Result in increased smooth endoplasmic reticulum. Induction of drug metabolism typically leads to the proliferation of smooth endoplasmic reticulum, which is essential for the detoxification and metabolism of various drugs, enhancing the liver's capacity to process these substances.
B: Result in increased rough endoplasmic reticulum. Rough endoplasmic reticulum is primarily associated with protein synthesis, not drug metabolism, making it unrelated to the effects of multiple drug therapy on liver function.
C: Result in decreased enzymes in the soluble cytoplasmic fraction. Metabolic induction generally increases enzyme levels in the liver, contradicting the notion of decreased enzymes in the cytoplasmic fraction due to drug therapy.
D: Require 3-4 months to reach completion. The effects of drug metabolism induction can occur more rapidly than this timeframe, often within days to weeks, depending on the substances involved.
The most consistent, pronounced and sustained relief of symptoms in chronic bronchial asthma is afforded by
Rationale:
D: Corticosteroids provide the most consistent, pronounced, and sustained relief of symptoms in chronic bronchial asthma by effectively reducing inflammation in the airways, thus improving airflow and overall respiratory function.
A: β₠sympathomimetics primarily focus on bronchodilation, offering temporary relief rather than addressing the underlying inflammation, which is crucial for long-term management of chronic asthma symptoms.
B: Anticholinergics can help with bronchodilation but do not adequately tackle the persistent inflammatory aspects of chronic bronchial asthma, limiting their effectiveness in providing sustained symptom relief.
C: Sodium cromoglycate is a preventive medication that stabilizes mast cells but lacks the comprehensive anti-inflammatory properties needed for pronounced and sustained symptom relief in chronic bronchial asthma.
What is symport?
Rationale:
Symport is cotransport. This process involves the simultaneous transport of two different substances across a cell membrane in the same direction, utilizing a specific transport protein to facilitate their movement together.
A: Counter transport Involves the simultaneous movement of two substances in opposite directions, which is distinct from the simultaneous transport characteristic of symport.
C: Carrier mediated diffusion This refers to a different mechanism where substances move along their concentration gradient without the concurrent transport of another molecule, thus differing from symport.
D: Solvent drug This term does not relate to transport mechanisms across membranes and instead refers to substances that dissolve drugs, making it irrelevant to the definition of symport.
A 51-year-old male patient with asthma has been prescribed an albuterol breathing treatment via small volume nebulizer. Before initiating the therapy, you note from the chart that the patient is severely hypertensive and has been experiencing episodes of supraventricular tachycardia. Which of the following actions should you take at this time?
Rationale:
C: Postpone the treatment and consult the physician. Given the patient's severe hypertension and episodes of supraventricular tachycardia, it is crucial to prioritize safety and ensure appropriate medical oversight before proceeding with any treatment that could exacerbate his condition.
A: Provide acetylcysteine instead of albuterol. Acetylcysteine serves a different purpose, primarily as a mucolytic agent, and is not suitable for treating acute asthma symptoms or addressing the patient's current complications.
B: Dilute the albuterol with extra normal saline. Diluting albuterol may not mitigate the risks associated with the patient's hypertensive state and tachycardia, potentially leading to further cardiovascular complications during treatment.
D: Administer the treatment as ordered. Administering albuterol without addressing the underlying cardiovascular issues presents a significant risk of worsening the patient's severe hypertension and tachycardia, potentially resulting in dangerous outcomes.
Relatively higher dose of theophylline is required to attain therapeutic plasma concentration in
Rationale:
Relatively higher dose of theophylline is required to attain therapeutic plasma concentration in smokers. Smokers have increased metabolic clearance of theophylline due to the induction of liver enzymes, necessitating larger doses to achieve effective blood levels and therapeutic benefits.
B: Congestive heart failure patients experience reduced clearance of theophylline, leading to a lower requirement for dosage to achieve therapeutic effects, contrary to the need for higher doses.
C: Those receiving erythromycin face potential interactions that increase theophylline levels, resulting in a decreased need for higher doses, as erythromycin inhibits theophylline metabolism.
D: Those receiving cimetidine have reduced theophylline clearance due to the inhibition of liver enzymes, meaning they require lower doses to maintain therapeutic plasma concentrations, opposite to higher dose requirements.
Concerning the inhaled asthma reliever salbutamol, which of the following is INCORRECT:
Rationale:
Salbutamol may produce bradycardia. This statement is incorrect as salbutamol primarily stimulates beta-2 adrenoceptors, leading to bronchodilation without significant effects on heart rate, which is typically associated with beta-1 stimulation.
A: It stimulate beta-2 adrenoceptors. Salbutamol effectively binds to beta-2 adrenoceptors, promoting bronchodilation, which is its primary mechanism of action in treating asthma symptoms.
C: It relax bronchial smooth muscle. Salbutamol's primary function is to relax bronchial smooth muscle, alleviating airway constriction and improving airflow in asthma patients.
D: It is used by inhalation or oral. Salbutamol can be administered via inhalation or orally, providing flexibility in treatment methods for individuals managing asthma.
You are called to administer a nebulized albuterol treatment to a 47-year-old female patient that is receiving oxygen via binasal cannula at 2 L/min. Her pretreatment heart rate was recorded at 84 beats/min. You would stop the treatment if the patient's heart rate were to reach which of the following:
Rationale:
A heart rate of 119 beats/min indicates a significant increase, suggesting the patient may be experiencing adverse effects from the nebulized albuterol treatment, necessitating cessation for safety.
A: 89 beats/min A heart rate of 89 beats/min does not signify a concerning increase, remaining within an acceptable range for a patient receiving treatment.
B: 99 beats/min A heart rate of 99 beats/min, while elevated, still falls below the threshold that would warrant stopping the nebulized treatment for the patient's safety.
C: 109 beats/min Reaching 109 beats/min is an increase, but it is not severe enough to justify halting treatment, as it remains manageable under clinical guidelines.
Budesonide is a
Rationale:
Budesonide is an inhaled corticosteroid for asthma. This medication works by reducing inflammation in the airways, making it easier for individuals with asthma to breathe and manage their symptoms effectively.
A: Nonsteroidal anti-inflammatory drug. Budesonide does not belong to this category, which primarily includes medications like ibuprofen that reduce pain and inflammation without steroid components.
B: High ceiling diuretic. Budesonide is unrelated to diuretics, which are used to promote urine production and manage fluid balance, differing fundamentally in their therapeutic applications.
D: Contraceptive. Budesonide has no role in contraception, as it is designed to address respiratory conditions, not to prevent pregnancy or regulate reproductive functions.
A 22-year-old female patient has just arrived to the emergency department with acute bronchospasm. Which of the following medications would you recommend?
Rationale:
Albuterol (Proventil) is the recommended medication for acute bronchospasm in this patient. As a short-acting beta-agonist, it rapidly relaxes bronchial smooth muscle, providing immediate relief from respiratory distress.
B: Racemic epinephrine primarily treats severe croup or stridor, not acute bronchospasm. Its primary action is vasoconstriction, which does not address the underlying bronchial constriction effectively.
C: Cromolyn sodium (Intal) serves as a prophylactic agent rather than a rescue medication. It takes time to exert its effects and is unsuitable for acute situations like bronchospasm.
D: Acetylcysteine (Mucomyst) is a mucolytic agent used to thin mucus, not a bronchodilator. It does not provide the immediate relief required for acute bronchospasm episodes.
The following drugs are used as 'standard of care' when treating a patient with type II (hypoxic-hypercapnic) respiratory failure:
Rationale:
A: 35 per cent oxygen. This option is appropriate as it provides a controlled increase in oxygen levels, essential for patients suffering from type II respiratory failure, alleviating hypoxia and enhancing oxygenation without exacerbating carbon dioxide retention.
B: Doxapram stimulates respiration but does not address the underlying hypoxia directly, making it less effective as a standard treatment for type II respiratory failure compared to oxygen therapy.
C: Salbutamol is a bronchodilator that primarily assists with airway obstruction rather than correcting hypoxic conditions, thus not serving as a foundational treatment for type II respiratory failure.
D: Methylprednisolone is a corticosteroid that reduces inflammation but does not specifically target the oxygenation needs or carbon dioxide retention associated with type II respiratory failure, making it less suitable.
A male patient was just prescribed an inhaled corticosteroid via MDI for two puffs twice a day. In order to decrease the likelihood of an oral infection, which of the following would you recommend that the patient do?
Rationale:
Rinse his mouth and gargle with water after inhalation.
This practice is essential for patients using inhaled corticosteroids, as it helps to clear residual medication from the mouth, significantly reducing the risk of developing oral infections such as thrush.
A: Receive concurrent bronchodilator therapy. While bronchodilator therapy may assist with airway dilation, it does not specifically address the prevention of oral infections associated with corticosteroid use.
B: Be prescribed an appropriate antibiotic. Antibiotics target bacterial infections, but they are not relevant for preventing oral infections caused by the use of inhaled corticosteroids, which are typically fungal.
C: Decrease the frequency to once per day. Reducing the frequency of inhaled corticosteroid use could diminish its therapeutic effects, potentially worsening the underlying condition and failing to mitigate oral infection risks.
Montelukast:
Rationale:
Montelukast is a competitive antagonist at the Cys LT1 receptor. This medication specifically targets the cysteinyl leukotriene receptor, blocking the action of leukotrienes involved in inflammatory processes, thus effectively managing asthma and allergic rhinitis symptoms.
B: Can be given orally. While montelukast is indeed available in oral form, this option does not address its mechanism of action, which is the focus of the question.
C: Is usually taken once daily at bedtime. Although the dosing schedule is relevant, it does not pertain to the pharmacological action of montelukast as a receptor antagonist.
D: May be associated with Churg-Strauss syndrome. This association is a potential adverse effect rather than a characteristic of the drug's function or mechanism, making it unrelated to the primary question.
The action of 5-Hydroxy tryptamine mediated by the 5-HT₃ receptor is
Rationale:
Bradycardia. The 5-HT₃ receptor activation by 5-Hydroxy tryptamine is linked to a reduction in heart rate, thus inducing bradycardia as a physiological response, highlighting its role in cardiac regulation.
A: Vasoconstriction 5-HT₃ receptor activity does not trigger vasoconstriction; instead, it is more associated with gastrointestinal motility and cardiovascular effects, not directly causing blood vessels to constrict.
C: EDRF release The 5-HT₃ receptor is not primarily involved in the release of Endothelium-Derived Relaxing Factor (EDRF); this function is typically attributed to other receptor types and mechanisms.
D: Platelet aggregation While serotonin influences platelet function, the 5-HT₃ receptor is not the main mediator of aggregation; other serotonin receptors play a more significant role in this process.
A 55-year-old patient that is receiving aerosol therapy with 0.9% saline is unable to produce an acceptable volume of sputum for a sample. Which of the following would you recommend at this time?
Rationale:
Change to hypertonic saline. Hypertonic saline can effectively induce sputum production by drawing more moisture into the airways, facilitating mucus clearance and improving sample volume for testing in patients unable to produce adequate sputum.
A: Initiate chest physiotherapy. While chest physiotherapy aids mucus clearance, it does not directly address the immediate need for increased sputum production in this scenario.
B: Administer the aerosol continuously. Continuous aerosol administration may not significantly enhance sputum volume as the patient still requires a more effective agent to stimulate mucus production.
D: Perform nasotracheal suctioning. This method may provide a sample but does not encourage natural sputum production and could cause discomfort or complications for the patient.
Fall in blood pressure caused by larger doses of histamine is blocked by
Rationale:
Combination of H₁ and H₂ antagonists. This combination effectively counteracts the blood pressure drop induced by higher histamine levels, as it simultaneously blocks the actions at both receptor sites, providing comprehensive relief.
A: H₁ antihistaminics alone. This option fails to address the H₂ receptor's role in blood pressure regulation, limiting its effectiveness in counteracting the hypotensive effects of histamine.
B: H₂ antagonists alone. Relying solely on H₂ antagonists neglects the crucial role of H₁ receptors in blood pressure dynamics, rendering this option insufficient in preventing blood pressure drops.
D: None of the above. This choice dismisses the possibility of using H₁ and H₂ antagonists together, which is vital for effectively blocking histamine-induced blood pressure decreases.
In the emergency department, the preferred first-line therapy for asthma exacerbation is
Rationale:
B: A β-agonist is the preferred first-line therapy for asthma exacerbation due to its rapid bronchodilation effect, effectively relieving acute symptoms by relaxing airway smooth muscles and improving airflow.
A: Theophylline acts as a bronchodilator but has a slower onset of action and potential side effects, making it less suitable for immediate relief during an asthma exacerbation.
C: A corticosteroid addresses inflammation but takes time to exert effects, thus not providing the rapid relief necessary during acute asthma episodes when immediate bronchodilation is required.
D: Cromolyn sodium is a preventive medication that stabilizes mast cells, which does not provide the urgent bronchodilation needed in an acute asthma exacerbation, rendering it ineffective in this scenario.
Histamine
Rationale:
May be released from mast cells by a number of therapeutic agents. This statement is accurate as various treatments, including certain medications, can stimulate mast cells to release histamine, which plays a pivotal role in allergic reactions and other physiological processes.
B: Causes sedation. Histamine primarily functions as a neurotransmitter that promotes wakefulness, not sedation, contradicting its known role in regulating sleep-wake cycles.
C: Decreases the force of contraction of ventricular muscle. Histamine typically increases heart rate and myocardial contractility, thereby enhancing the force of contraction rather than diminishing it.
D: Can cause strong contractions of the gravid human uterus. While histamine does have various physiological effects, strong uterine contractions are more closely associated with other agents like oxytocin, not histamine.
Which of the following is most useful in the treatment of hyperprolactinemia?
Rationale:
Bromocriptine is most useful in the treatment of hyperprolactinemia. This medication acts as a dopamine agonist, effectively lowering prolactin levels by stimulating dopamine receptors, which helps restore hormonal balance in patients experiencing hyperprolactinemia-related symptoms.
B: Cimetidine inhibits certain receptors, primarily affecting gastric acid secretion, and has no direct impact on prolactin levels, making it unsuitable for treating hyperprolactinemia.
C: Ergotamine is primarily used for migraine treatment and does not specifically target prolactin regulation, thus lacking efficacy in managing hyperprolactinemia conditions.
D: Ketanserin functions as an antagonist for serotonin receptors and does not possess any significant role in modulating prolactin secretion, rendering it ineffective for hyperprolactinemia treatment.
A patient suffering from 'status asthmaticus' presents in the emergency room. Which of the following in its parenteral form is life saving for this patient, and acts by inhibition of phospholipase $A_2$?
Rationale:
Dexamethasone/prednisolone is life-saving in status asthmaticus as it effectively inhibits phospholipase A2, reducing inflammation and bronchoconstriction, thus improving airflow and patient condition in acute exacerbations.
A: Aminophylline primarily acts as a bronchodilator, enhancing airflow but does not directly inhibit phospholipase A2. Its mechanism is not sufficient for immediate inflammatory control in severe asthma cases.
B: Cromolyn stabilizes mast cells and prevents the release of mediators but does not inhibit phospholipase A2. It is more effective in chronic management rather than acute status asthmaticus situations.
C: Epinephrine acts as a bronchodilator through beta-adrenergic stimulation, providing rapid relief. However, it does not target phospholipase A2 inhibition, limiting its ability to control inflammation.
Acute exacerbations of asthma can be triggered by all of the following except
Rationale:
Acute exacerbations of asthma can be triggered by hot, dry weather.
Hot, dry weather does not typically provoke asthma symptoms. Instead, it can have a neutral or even beneficial impact on air quality and respiratory comfort, contrasting with the other options that directly influence asthma exacerbation mechanisms.
A: Bacterial or viral pneumonia can lead to increased inflammation and airway obstruction, triggering severe asthma symptoms and exacerbations due to heightened respiratory distress.
B: Hypersensitivity reaction to penicillin often results in allergic responses that can provoke asthma symptoms by causing airway inflammation and bronchoconstriction in sensitive individuals.
C: Discontinuation of asthma medication removes essential control over inflammation and airway responsiveness, often leading to worsening asthma control and increased likelihood of acute exacerbations.
In a patient of bronchial asthma, inhaled salbutamol produces the following effect(s).
Rationale:
Inhaled salbutamol causes bronchodilatation. This medication works as a selective beta-2 adrenergic agonist, relaxing bronchial smooth muscle and leading to widening of the airways, which is crucial for asthma management.
A: Inhibits antigen-antibody reaction in the lungs. Salbutamol does not target immune mechanisms; it primarily acts on bronchial smooth muscle to alleviate constriction rather than modifying immune responses.
C: Reduces bronchial hyperreactivity. While salbutamol improves airway function, it does not directly address hyperreactivity, which involves underlying inflammatory processes rather than merely relaxing bronchial muscles.
D: Both (b) and (c). Although bronchodilatation is a key effect, salbutamol does not effectively reduce bronchial hyperreactivity, making this combined option misleading in its implications.
Which of the following is a prophylactic agent that appears to stabilize mast cells?
Rationale:
B: Cromolyn is a prophylactic agent that stabilizes mast cells, preventing the release of inflammatory mediators such as histamine. Its mechanism helps manage allergic responses and asthma symptoms effectively.
A: Aminophylline primarily acts as a bronchodilator and does not have a stabilizing effect on mast cells, focusing instead on relaxing airway muscles for improved airflow.
C: Epinephrine functions as a vasoconstrictor and bronchodilator during acute allergic reactions but does not stabilize mast cells, as its role centers around immediate symptom relief rather than prevention.
D: Ipratropium is an anticholinergic medication that helps manage bronchospasm by blocking acetylcholine receptors, lacking any direct action on mast cell stabilization or prophylactic properties in allergic conditions.
The smooth muscle stimulating action of 5-HT is most marked in the
Rationale:
The smooth muscle stimulating action of 5-HT is most marked in the intestines. This is due to 5-HT’s pivotal role in promoting gut motility and regulating peristalsis, essential for effective digestion and absorption of nutrients. Its influence is particularly pronounced in the intestinal smooth muscle, where it enhances contractions and facilitates movement through the gastrointestinal tract.
A: Bronchi 5-HT’s action in the bronchi primarily involves vasodilation and bronchoconstriction, which are less marked compared to its effects on intestinal smooth muscle.
C: Ureter While 5-HT does impact ureteral smooth muscle, its effects are significantly less pronounced than in the intestines, which are more responsive to this neurotransmitter.
D: Biliary tract The biliary tract experiences some influence from 5-HT, yet the stimulation of smooth muscle is not as marked as in the intestines, where contractions are more critical for function.
The antihistamine which has calcium channel blocking and labyrinthine suppressant property is
Rationale:
B: Cinnarizine has calcium channel blocking and labyrinthine suppressant properties, making it effective for conditions like motion sickness and vestibular disorders, distinguishing it from other antihistamines in therapeutic use.
A: Cyproheptadine primarily acts as an antihistamine and appetite stimulant, lacking the specific calcium channel blocking and labyrinthine suppressant effects characteristic of cinnarizine.
C: Clemastine primarily functions as an antihistamine without the additional calcium channel blocking properties, limiting its applicability in conditions requiring such effects for treatment.
D: Cetirizine, while an effective antihistamine for allergies, does not possess calcium channel blocking or labyrinthine suppressant properties, making it unsuitable for treating related vestibular disorders.
A 16-year-old patient is in the emergency room receiving nasal oxygen. She has a heart rate of $135 /min$, a respiratory rate of $40/min$. Wheezing and rales are audible without a stethoscope. Which of the following drugs does NOT have a direct bronchodilator effect?
Rationale:
Nedocromil does NOT have a direct bronchodilator effect. Instead, it primarily functions as a mast cell stabilizer, preventing the release of inflammatory mediators and thus reducing bronchoconstriction indirectly over time.
A: Epinephrine Directly stimulates adrenergic receptors, effectively causing immediate bronchodilation in acute asthma attacks and respiratory distress, making it a potent bronchodilator option in emergencies.
B: Terbutaline A selective beta-2 adrenergic agonist, Terbutaline provides rapid bronchodilation by relaxing bronchial smooth muscle, making it a critical medication for asthma and other obstructive airway diseases.
D: Theophylline Acts as a bronchodilator through phosphodiesterase inhibition and adenosine receptor antagonism, thereby increasing cAMP levels in airway smooth muscle, resulting in relaxation and improved airflow.
The following drugs can be used in treatment of bronchial asthma EXCEPT:
Rationale:
D: Carbachol is not used in the treatment of bronchial asthma as it primarily functions as a muscarinic agonist that can cause bronchoconstriction, contrary to the treatment goals for asthma management.
A: Aminophylline serves as a bronchodilator and is effective in asthma treatment, enhancing respiratory airflow by relaxing bronchial smooth muscles.
B: Salbutamol, a short-acting beta-agonist, provides rapid relief from asthma symptoms by dilating the airways, making it a valuable medication in asthma management.
C: Ketotifen is an antihistamine that helps prevent asthma attacks by reducing allergic responses, thus playing a beneficial role in asthma treatment protocols.
Terbutaline specifically stimulates:
Rationale:
Terbutaline specifically stimulates Beta 2 receptors. This medication primarily acts on beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation and providing relief from bronchospasm in conditions like asthma.
A: Alpha 1 receptors Activation of these receptors primarily causes vasoconstriction, which does not align with terbutaline's primary function of relaxing bronchial muscles for respiratory relief.
B: Alpha 2 receptors Stimulation of alpha-2 receptors generally results in inhibition of neurotransmitter release, playing a minimal role in respiratory effects, unlike terbutaline's action on beta-2 receptors.
C: Beta 1 receptors These receptors are mainly located in the heart, and their activation increases heart rate and contractility, which is not the therapeutic aim of terbutaline.
In the emergency department, the preferred first-line therapy for asthma exacerbation is
Rationale:
In the emergency department, the preferred first-line therapy for asthma exacerbation is a β-agonist.
β-agonists rapidly relax bronchial smooth muscle, providing immediate relief from bronchoconstriction during asthma exacerbations. Their quick action helps alleviate symptoms and improve airflow, making them essential in emergency treatment protocols for asthma.
A: Theophylline Theophylline works as a bronchodilator but has a slower onset of action, making it less suitable for immediate relief during acute asthma attacks.
C: A corticosteroid Corticosteroids are effective for long-term control of inflammation but take time to exert their effects, thus not ideal for acute symptom management in emergencies.
D: Cromolyn sodium Cromolyn sodium is a preventative medication that stabilizes mast cells but does not provide rapid relief during an asthma exacerbation, limiting its usefulness in acute situations.